Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Shawn Singh currently holds 18,028 shares of Echo Therapeutics, Inc. (ECTE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Shawn Singh has been a net buyer of ECTE stock. They have purchased $102.0K and sold $0 worth of shares.
Shawn Singh's most recent insider trade was on Jun 30, 2025, when they sold 7,541 shares at $1.70 per share.
Shawn Singh serves as Executive at Echo Therapeutics, Inc. (ECTE). They have executed 24 insider transactions totaling $102.0K over their tenure at the company.
Shawn Singh holds the position of Executive at Echo Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 19 years and currently hold a stake valued at $0.
Shawn Singh has shown a buying trading pattern, with $102.0K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Shawn Singh was on May 11, 2011, when they purchased $266.3K worth of EXCA shares. This transaction involved 76,087 shares at $3.50 per share.
Shawn Singh currently owns 18,028 shares of Echo Therapeutics, Inc. (ECTE), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Shawn Singh's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Shawn Singh has 24 Form 4 filings on record as an insider at Echo Therapeutics, Inc..
Set alerts for Shawn Singh and 40,000+ other insiders.